YWS
ABBV icon

Yarger Wealth Strategies’s AbbVie ABBV Stock Holding History

Yarger Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
4,106
+374
+10% +$80.5K 0.37% 54
2026
Q1 		$812K Buy
3,732
+617
+20% +$137K 0.33% 56
2025
Q4 		$712K Buy
3,115
+145
+5% +$33K 0.31% 58
2025
Q3 		$688K Sell
2,970
-455
-13% -$92.7K 0.32% 54
2025
Q2 		$636K Sell
3,425
-141
-4% -$26.2K 0.33% 54
2025
Q1 		$747K Buy
3,566
+144
+4% +$28K 0.44% 46
2024
Q4 		$608K Buy
3,422
+2,031
+146% +$373K 0.35% 46
2024
Q3 		$275K Buy
1,391
+32
+2% +$5.97K 0.15% 74
2024
Q2 		$233K Buy
1,359
+28
+2% +$4.64K 0.14% 77
2024
Q1 		$242K Buy
1,331
+33
+3% +$5.69K 0.17% 69
2023
Q4 		$201K Buy
+1,298
New +$189K 0.16% 64

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Yarger Wealth Strategies's ABBV Position: Q2 2026 in Review

Yarger Wealth Strategies increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $80.5K and bringing the position to 4,106 shares worth $1.02M. The position accounts for 0.37% of the portfolio, ranked #54.

Yarger Wealth Strategies first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Yarger Wealth Strategies held 4,106 shares of AbbVie worth $1.02M as of Q2 2026.
  • Yarger Wealth Strategies bought 374 AbbVie shares in Q2 2026, an estimated $80.5K.
  • AbbVie made up 0.37% of Yarger Wealth Strategies's portfolio in Q2 2026, its #54 holding.
  • Yarger Wealth Strategies first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Yarger Wealth Strategies's 13F filing for Q2 2026, filed 14 Jul 2026.